‍Extracellular Vesicles from Microalgae (MEV) as Delivery Systems.

2-billion-year-old technology, unleashed.
Arrow
learn more

WHAT WE DO

As a Contract Development and Manufacturing Organization, we develop industry-scale processes for the manufacture of microalgae extracellular vesicles (MEV) for multiple purposes; non-GMP and cGMP-compliant.
Our current manufacturing capacity gauges between 500 and 600L per MEV batch.

Management TEAM
Manuel VEGA
Founder, CEO
Lila DRITTANTI
Founder, COO & Product Development
Lionel NAVARRO
Founder, Scientific Advisor
Marie-Hélène LEOPOLD
Founder, Market Intelligence
advisory board
  • Alex CHANAS
  • Director, several health companies, UK. Exec. Director, Worldwide Business Development, PFIZER (1997-2011).
  • Charles DETAISNE
  • CEO, ANTINEO SAS, France. Sr. Director, Corporate Development, SANOFI PASTEUR (2003-2015).
  • Eric QUEMENEUR
  • Exec. VP, CSO, TRANSGENE, France Director, Research & Industrial Partnerships, CEA (1990-2014).
  • Fayza DABOUSSI
  • CSO, TWB, France. Research Director, INRA, France. VP, Synthetic Biology, CELLECTIS (2008-2014).
  • Jérémy PRUVOST
  • Director, ALGOSOLIS, France. Director, GEPEA, France. Head of Research, Microalgae, GEPEA (2011-2018). Co-Director, SPI Doctoral School, Univ. Nantes (2012-2016).
  • Ron NEWBOLD
  • CBO, SPINOGENIX Inc., USA. Sr. VP, CBO, US, OTSUKA Pharmaceutical (2017-2019). VP External R&D Innovation, PFIZER (2010-2017).
partners
© 2023 AGS-M ALL RIGHTS RESERVED
LINK
HOMEPARTNERScontact
lET'S TALK

We welcome biotech companies eager to collaborate, researchers looking to expand our body of knowledge, investors funding the next generation of bio-platforms, and professionals ready to be part of the future of biotech.